Biosimilars Activities
Adopting Oncology Biosimilars Into Clinical Practice: How Pharmacists Can Help Pave the Way
0290-0000-20-319-H01-P
This activity will apply knowledge of the challenges associated with the adoption of biosimilars into clinical practice to a real-world patient and clinician counseling scenario.
1.50
Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data When Treating Inflammatory Conditions
0290-0000-20-298-H01-P
This activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.
1.00
Use of Oncology Supportive Care Biosimilars During COVID-19: Clinical Strategies for Pharmacists
0290-0000-20-171-H01-P
This activity will provide pharmacists with an overview of growth factor biosimilars, with an emphasis on use for neutropenia and alternative approaches during the pandemic.
2.00
Incorporating the Use of Biosimilars into Clinical Practice: Opportunities for Pharmacists to Intervene
0290-0000-20-191-H03-P
This activity will review the approval process and required nomenclature for biosimilars as well as the differences between biosimilars and biologics.
1.00